UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future

Journal of molecular endocrinology, 2020-07, Vol.65 (1), p.T49-T63

2020

Volltextzugriff (PDF)

Progesterone receptors, their isoforms and progesterone regulated transcription

Molecular and cellular endocrinology, 2012-06, Vol.357 (1-2), p.18-29

2012

Volltextzugriff (PDF)

Post-translational modifications of the progesterone receptors

The Journal of steroid biochemistry and molecular biology, 2014-03, Vol.140, p.80-89

2014

Volltextzugriff (PDF)

Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling

BMC cancer, 2014-10, Vol.14 (1), p.735-735, Article 735

2014

Volltextzugriff (PDF)

Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells

Breast cancer research : BCR, 2014-12, Vol.16 (6), p.489-489, Article 489

2014

Volltextzugriff (PDF)

Response to: Progesterone and breast cancer pathogenesis

Journal of molecular endocrinology, 2021-01, Vol.66 (1), p.L1-L2

2021

Volltextzugriff (PDF)

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

Proceedings of the National Academy of Sciences - PNAS, 2008-04, Vol.105 (15), p.5774-5779

2008

Volltextzugriff (PDF)

Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis

The journal of clinical endocrinology and metabolism, 2008-09, Vol.93 (9), p.3295-3298

2008

Volltextzugriff (PDF)

Role of epigenetic modifications in luminal breast cancer

Epigenomics, 2015-08, Vol.7 (5), p.847-862

2015

Volltextzugriff (PDF)

Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch

Proceedings of the National Academy of Sciences - PNAS, 2012-02, Vol.109 (8), p.2742-2747

2012

Volltextzugriff (PDF)

The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling

The Journal of clinical investigation, 2009-09, Vol.119 (9), p.2678-2690

2009

Volltextzugriff (PDF)

The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk

Molecular endocrinology (Baltimore, Md.), 2008-12, Vol.22 (12), p.2743

Horwitz, Kathryn B

2008

Volltextzugriff (PDF)

Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells

The Journal of biological chemistry, 2002-02, Vol.277 (7), p.5209-5218

2002

Volltextzugriff (PDF)

Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers

Breast cancer research and treatment, 2011-07, Vol.128 (1), p.45-55

2011

Volltextzugriff (PDF)

The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (7), p.3893-3902

2006

Volltextzugriff (PDF)

Phosphorylation of Human Progesterone Receptors at Serine-294 by Mitogen-Activated Protein Kinase Signals Their Degradation by the 26S Proteasome

Proceedings of the National Academy of Sciences - PNAS, 2000-02, Vol.97 (3), p.1032-1037

2000

Volltextzugriff (PDF)

Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation

BMC molecular biology, 2012-03, Vol.13 (1), p.10-10

2012

Volltextzugriff (PDF)

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease

Modern pathology, 2008-07, Vol.21 (7), p.912-923

2008

Volltextzugriff (PDF)

ER,PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer- Reduced CK5 Expression in Metastases

Breast Cancer: Basic and Clinical Research, 2013-01, Vol.2013 (2013), p.23-34

2013

Volltextzugriff (PDF)

Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates

Clinical cancer research, 2004-04, Vol.10 (8), p.2751-2760

2004

Volltextzugriff (PDF)

Estrogen receptor positive breast cancer metastasis : Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (18), p.9308-9315

2006

Volltextzugriff (PDF)

Regulation of the SUMO Pathway Sensitizes Differentiating Human Endometrial Stromal Cells to Progesterone

Proceedings of the National Academy of Sciences - PNAS, 2006-10, Vol.103 (44), p.16272-16277

2006

Volltextzugriff (PDF)

Fibroblast subtypes define a metastatic matrisome in breast cancer

JCI insight, 2020-02, Vol.5 (4)

2020

Volltextzugriff (PDF)

Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation

The Journal of biological chemistry, 2009-04, Vol.284 (14), p.9099-9108

2009

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Secreted by Activated Stroma Enhances Angiogenesis and Hormone-Independent Growth of Estrogen Receptor-Positive Breast Cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (7), p.2655-2664

2010

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(207)

Publikationsform

Sprache

Englisch
(231)

Erscheinungsjahr

n.n

Thema

Humans
(144)
Science & Technology
(140)
Life Sciences & Biomedicine
(131)
Female
(91)
Biological And Medical Sciences
(74)
Medical Sciences
(58)
Animals
(57)
Receptors, Progesterone - Metabolism
(48)
Breast Neoplasms - Metabolism
(46)
Oncology
(42)
Tumors
(41)
Biochemistry & Molecular Biology
(39)
Endocrinology & Metabolism
(38)
Breast Neoplasms - Pathology
(35)
Mice
(33)
Gynecology. Andrology. Obstetrics
(29)
Receptors, Progesterone - Genetics
(29)
Breast Cancer
(27)
Tumor Cells, Cultured
(27)
Pharmacology. Drug Treatments
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future

Progesterone receptors, their isoforms and progesterone regulated transcription

Post-translational modifications of the progesterone receptors

Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling

Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells

Response to: Progesterone and breast cancer pathogenesis

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis

Role of epigenetic modifications in luminal breast cancer

Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch

The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling

The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk

Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells

Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers

The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers

Phosphorylation of Human Progesterone Receptors at Serine-294 by Mitogen-Activated Protein Kinase Signals Their Degradation by the 26S Proteasome

Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease

ER,PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer- Reduced CK5 Expression in Metastases

Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates

Estrogen receptor positive breast cancer metastasis : Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes

Regulation of the SUMO Pathway Sensitizes Differentiating Human Endometrial Stromal Cells to Progesterone

Fibroblast subtypes define a metastatic matrisome in breast cancer

Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation

Vascular Endothelial Growth Factor Secreted by Activated Stroma Enhances Angiogenesis and Hormone-Independent Growth of Estrogen Receptor-Positive Breast Cancer

Suchergebnisse filtern